We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

专家建议减少住院患者的检验次数

By LabMedica International staff writers
Posted on 21 Dec 2017
Print article
图像:收集人血样做检验;过多的检验可能引起医院获得性贫血(图片蒙Rebecca Zeffert惠赐)。
图像:收集人血样做检验;过多的检验可能引起医院获得性贫血(图片蒙Rebecca Zeffert惠赐)。
住院患者的日常化验反映了临床业务的浪费,它威胁着医疗护理的价值。大量职业社团主张把以临床稳定性为名的重复化验认定为无价值医疗。

过多的静脉切开术可能导致医院获得性贫血,增加开支,引起不必要的下游检验和手术。努力降低化验频度会提高病人满意度,减少成本,且不会对病人预后造成不良影响。

美国马里兰州巴尔的摩市约翰霍普金斯大学医学院的内科医师与北美其它几家单位的专家编制并草拟了一份基于经验的质量改进计划,以减少住院患者的重复化验。作者引用的各项研究都显示,一线医疗工作者化验的请求量减少了8%到19%,作者报告说,每年节省的费用范围是60万美元到200万美元。

专家建议,有必要设计以数据为支撑的全医院培训计划,共同勾勒和标准化最佳实践。确立要减少的化验请求的数量目标,向送检医师提供即时反馈,显示他们个人送检的模式,他们因此能意识到自己的行为不符合已得到一致认可的标准。也可以修改用于请求化验的电子系统的程序,限制“预订”化验的数量,同时留意是否有更好的送检原因,而不是机械地天天送检。

迄今已在多家机构部署了大量干预措施,但没有一个标准方法。医疗工作者和行政领导应该仔细制定行动策略,并优化工作方式,以减少每天的化验次数。已发表的论文显示,减少重复的日常化验不会导致漏诊或增加再次入院的数量。

该研究的论文发表于2017年10月16日的《JAMA》杂志《内科》分册。领衔作者、第三年的内科住院医师Kevin P. Eaton博士说:“抽血次数过多可能耗尽病人的血红蛋白,这又经常导致重复化验。有人估计近20%的住院患者会得中度到重度的医院获得性贫血。如此反复会给病人带来更多不必要的检验、干预和花销。”

Related Links:
约翰霍普金斯大学医学院

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more